AzTrials
AzTrials

Shoulder DislocationHYPSEMNCT04992598

Hypnosis to Reduce Pain and Drugs for Shoulder Dislocation Management

A study testing Hypnosis session and Reduction in people with Shoulder Dislocation, run by Centre Hospitalier Régional Metz-Thionville at 7 sites in France.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

The effectiveness of hypnosis for reducing pain was evaluated in various medical specialities. However, only few studies have demonstrated the efficacy of hypnosis for the management of pain in the emergency medicine. Anteromedial dislocation is a very common Reason for admission in emergency department. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Shoulder Dislocation
What is being tested?
Hypnosis session and Reduction
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
0 participants
Where
7 sitesFrance
Study dates
1 Jun 2024to 1 Aug 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients aged 18 years and over,
  • Checked into ED for an anterior shoulder dislocation suspected by clinical examination and confirmed by radiography,
  • Had given oral consent to participate in the study
  • Are affiliated or be a recipient of a social security plan.
  • A staff member (nurse, nurse's aide, or physician) trained in hypnosis is available at the patient admission time.

Who cannot join

  • Patient showing up with a shoulder fracture on x-ray.
  • Patient presenting a shoulder prosthesis.
  • Patient with recurrent dislocations.
  • Patient who does not speak or understand French language.
  • Patient with cognitive dysfunction.
  • Patient with a psychiatric history of psychosis.
Show all 10Show fewer
  • Patient who is deaf or hard of hearing.
  • Patient under legal protection (guardianship, curatorship).
  • Pregnant women
  • Patient who already benefited of a pre-hospital reduction

Trial locations and contacts

7 sites in 1 country.

7 sites in 1 country

France7 sites
  • CHR Fleyriat- Hôpital de Bourg en Bresse

    Bourg-en-Bresse, Ain, 01000

  • Centre Hospitalier Saint Luc Saint Joseph

    Lyon, Rhône, 69007

  • Groupement hospitalier Sud-Hôpital Lyon Sud

    Lyon, Rhône, 69495

  • CHR Metz Thionville

    Metz, Moselle, 57085

  • Hôpital Robert Pax

    Sarreguemines, Moselle, 57200

  • Centre Hospitalier Lucien Hussel

    Vienne, Isère, 38209

  • Hôpital Nord-Ouest Villefranche sur Saône

    Villefranche-sur-Saône, Rhône, 69655

Other trials in France

About this study

Official title: Hypnosis to Reduce Pain and Drugs for Shoulder Dislocation Management in the Emergency Department

The effectiveness of hypnosis for reducing pain was evaluated in various medical specialities. However, only few studies have demonstrated the efficacy of hypnosis for the management of pain in the emergency medicine.

Anteromedial dislocation is a very common Reason for admission in emergency department. Many methods for reduction have been described but there is no consensus on the optimum technique or sedation procedures.

Read more

Some pain medication and tranquilizers used during a shoulder dislocation management include hemodynamic, respiratory and behavioral adverse effects with the requirement of strengthened surveillance.

Hypnosis could provide to reduce sedative and analgesic use during the reduction of anteromedial dislocation.

The main objective of this study is to evaluate the efficacy of a hypnosis session for reducing the consumption of analgesic in patient throughout a reduction of shoulder dislocation.

The investigators also examine the effect of hypnosis on hemodynamic parameters, patient's pain, patient and practitioner satisfaction, sedative consumption, number of attempts for reduction and length of stay in the emergency department.

Being tested
Hypnosis session, Reduction
Keywords
Hypnosis
Medical subject headings
Shoulder Dislocation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hypnosis sessionOther

    Hypnosis session will precede therapeutic strategies and reduction

  • ReductionProcedure or surgery

    All dislocation would be reduced Under adequate analgesia and sufficient sedation. All methods for reduction can be used.

Study groups in NCT04992598
Study groupRoleWhat they receive
Hypnosis groupExperimentalNot described
Receives: Other: Hypnosis session; Procedure: Reduction
Control groupPlacebo comparatorNot described
Receives: Procedure: Reduction

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Analgesic consumption

    Calculated as the equal dose of morphine

    Measured: Day 1

Secondary outcomes (7)
  1. Dose of sedative drug

    Dose of sedative drug

    Measured: Day 1

  2. Patients'satisfaction

    Patients'satisfaction was assessed with a Likert scale after reduction. The satisfaction was scored on 5-point Likert scale, ranging from 1 to 5 (with 1=excellent and 5=catastrophic).

    Measured: Day 1

  3. Practitioners'satisfaction

    Practitioners'satisfaction was assessed with a Likert scale after reduction. The satisfaction was scored on 5-point Likert scale, ranging from 1 to 5 ( with 1=excellent and 5=catastrophic).

    Measured: Day 1

  4. Number of attempts for reduction

    Number of attempts for reduction

    Measured: Day 1

  5. Length of stay

    Length of stay in the emergency department

    Measured: Day 1

  6. Method use for reduction

    Method use for reduction

    Measured: Day 1

  7. Adverse events

    number of adverse events

    Measured: Day 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Aug 2021
  2. Study start1 Jun 2024 (estimated)
  3. Primary completion1 Jul 2024 (estimated)
  4. Study completion1 Aug 2024 (estimated)

Why it stopped: departure of the study coordinating investigator

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04992598
Sponsor's protocol ID
2021-02-CHRMT
Acronym
HYPSEM
Status last verified
May 2024
First submitted
28 Jul 2021
Last updated
30 May 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Tinelli M, Guler N, Goetz C, Aim P, Marchionni S, Ouamara N, Cipolat L, Demarquet M, Seris E, Moreau A, Durand G, Douplat M, Lavignon JP, Hingray C, Abensur Vuillaume L. Study protocol: hypnosis versus standard care for shoulder dislocation reduction in the emergency department - a multicentre, randomised, controlled study protocol. BMJ Open. 2022 Dec 7;12(12):e062278. doi: 10.1136/bmjopen-2022-062278.

    PubMed 36600368

Questions about this trial

What is this clinical trial studying?

A study testing Hypnosis session and Reduction in people with Shoulder Dislocation, run by Centre Hospitalier Régional Metz-Thionville at 7 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 30 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 7 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Analgesic consumption (time frame: Day 1). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04992598, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in